Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With Cabazitaxel.

Qaid Ahmed Shagera,Ioannis Karfis,Spyridon Sideris,Thomas Guiot,Erwin Woff,Nieves Martinez-Chanza,Thierry Roumeguere,Thierry Gil,Patrick Flamen,Carlos Artigas

Clinical nuclear medicine（2023）

引用 1|浏览6

暂无评分

摘要

Our results show that total tumor volume measured on PSMA PET/CT is a prognostic biomarker in patients treated with cabazitaxel. High PSMA-TV before treatment initiation is associated with shorter PFS and OS.

查看译文

关键词

biomarker, cabazitaxel, PET, CT, prognostic, prostate cancer, PSMA

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要